Should doctors prescribe lecanemab (Leqembi) to women? The answer, given available evidence, is probably No
This article is an edited combination of two previous blog posts by him at www.skin2neuron.org.
News in Context:
CMS: anti-amyloid drug Leqembi (lecanemab) doesn’t meet the “reasonable and necessary” standard required for wider Medicare coverage
The post Should doctors prescribe lecanemab (Leqembi) to women? The answer, given available evidence, is probably No appeared first on SharpBrains.
Source: SharpBrains - Category: Neuroscience Authors: Prof. Michael Valenzuela Tags: Brain/ Mental Health amyloid amyloid antibodies amyloid removal CLARITY trial Clinical Dementia Rating immunotherapy lecanemab Leqembi women Source Type: blogs
More News: Academia | Australia Health | Biotechnology | Bleeding | Blogging | Brain | Dementia | Harvard | Immunotherapy | International Medicine & Public Health | Medicare | Men | Neurology | Neuroscience | PET Scan | Statistics | Stroke | Study | Wales Health | WHO | Women